Miciak J, Petrova L, Sajwan R, Pandya A, Deckard M, Munoz A
Oncotarget. 2025; 16:79-100.
PMID: 39969205
PMC: 11837864.
DOI: 10.18632/oncotarget.28690.
Takikawa M, Nakano A, Krishnaraj J, Tabata Y, Watanabe Y, Okabe A
Proc Natl Acad Sci U S A. 2025; 122(6):e2413126122.
PMID: 39913207
PMC: 11831151.
DOI: 10.1073/pnas.2413126122.
Wang Y, Armendariz D, Wang L, Zhao H, Xie S, Hon G
Genome Biol. 2025; 26(1):10.
PMID: 39825430
PMC: 11740497.
DOI: 10.1186/s13059-025-03474-0.
Xiao C, Zhang X, Hou B, Wan P, Cao Z, Rao X
Discov Oncol. 2024; 15(1):847.
PMID: 39739214
PMC: 11685368.
DOI: 10.1007/s12672-024-01650-5.
Szebenyi K, Vargova I, Petrova V, Tureckova J, Gibbons G, rehorova M
Brain Commun. 2024; 6(4):fcae244.
PMID: 39144751
PMC: 11323778.
DOI: 10.1093/braincomms/fcae244.
Skeletal muscle-on-a-chip in microgravity as a platform for regeneration modeling and drug screening.
Kim S, Ayan B, Shayan M, Rando T, Huang N
Stem Cell Reports. 2024; 19(8):1061-1073.
PMID: 39059375
PMC: 11368695.
DOI: 10.1016/j.stemcr.2024.06.010.
Epigenetic modification of PHLDA2 is associated with tumor microenvironment and unfavorable outcome of immune checkpoint inhibitor-based therapies in clear cell renal cell carcinoma.
Zhao J, Pan X, Wang Z, Chen Y, Liu D, Shen Y
Eur J Med Res. 2024; 29(1):378.
PMID: 39033192
PMC: 11264912.
DOI: 10.1186/s40001-024-01939-9.
Implications of noncoding regulatory functions in the development of insulinomas.
Ramos-Rodriguez M, Subirana-Granes M, Norris R, Sordi V, Fernandez A, Fuentes-Paez G
Cell Genom. 2024; 4(8):100604.
PMID: 38959898
PMC: 11406191.
DOI: 10.1016/j.xgen.2024.100604.
Multiomics Analysis of the PHLDA Gene Family in Different Cancers and Their Clinical Prognostic Value.
Iqbal S, Karim M, Mohammad S, Mathiyalagan R, Morshed M, Yang D
Curr Issues Mol Biol. 2024; 46(6):5488-5510.
PMID: 38921000
PMC: 11201736.
DOI: 10.3390/cimb46060328.
Screening of factors inducing alveolar type 1 epithelial cells using human pluripotent stem cells.
Ohnishi Y, Masui A, Suezawa T, Mikawa R, Hirai T, Hagiwara M
Stem Cell Reports. 2024; 19(4):529-544.
PMID: 38552636
PMC: 11096435.
DOI: 10.1016/j.stemcr.2024.02.009.
Single-cell and bulk transcriptional profiling of mouse ovaries reveals novel genes and pathways associated with DNA damage response in oocytes.
Mills M, Emori C, Kumar P, Boucher Z, George J, Bolcun-Filas E
bioRxiv. 2024; .
PMID: 38352597
PMC: 10862846.
DOI: 10.1101/2024.02.02.578648.
Redifferentiated cardiomyocytes retain residual dedifferentiation signatures and are protected against ischemic injury.
Shakked A, Petrover Z, Aharonov A, Ghiringhelli M, Umansky K, Kain D
Nat Cardiovasc Res. 2023; 2(4):383-398.
PMID: 37974970
PMC: 10653068.
DOI: 10.1038/s44161-023-00250-w.
Magnolol Supplementation Alters Serum Parameters, Immune Homeostasis, Amino Acid Profiles, and Gene Expression of Amino Acid Transporters in Growing Pigs.
Liu Y, Li Y, Yu M, Tian Z, Deng J, Ma X
Int J Mol Sci. 2023; 24(18).
PMID: 37762256
PMC: 10530316.
DOI: 10.3390/ijms241813952.
Metabolic intervention by low carbohydrate diet suppresses the onset and progression of neuroendocrine tumors.
Chen Y, Yamamoto T, Takahashi Y, Moro T, Tajima T, Sakaguchi Y
Cell Death Dis. 2023; 14(9):597.
PMID: 37679316
PMC: 10484927.
DOI: 10.1038/s41419-023-06123-1.
Single-cell RNA sequencing to detect age-associated genes that identify senescent cells in the liver of aged mice.
Doshida Y, Hashimoto S, Iwabuchi S, Takino Y, Ishiwata T, Aigaki T
Sci Rep. 2023; 13(1):14186.
PMID: 37648885
PMC: 10468526.
DOI: 10.1038/s41598-023-41352-6.
A novel stratification framework based on anoikis-related genes for predicting the prognosis in patients with osteosarcoma.
Zhang X, Wen Z, Wang Q, Ren L, Zhao S
Front Immunol. 2023; 14:1199869.
PMID: 37575253
PMC: 10413143.
DOI: 10.3389/fimmu.2023.1199869.
Characterizing the role of Phlda3 in the development of acute toxicity and malignant transformation of hematopoietic cells induced by total-body irradiation in mice.
Hasapis S, Caraballo I, Sears T, Brock K, Cart J, Moding E
Sci Rep. 2023; 13(1):12916.
PMID: 37558703
PMC: 10412554.
DOI: 10.1038/s41598-023-39678-2.
Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition.
Hassel J, Zimmer L, Sickmann T, Eigentler T, Meier F, Mohr P
Cancers (Basel). 2023; 15(13).
PMID: 37444558
PMC: 10341224.
DOI: 10.3390/cancers15133448.
p53-Dependent Cytoprotective Mechanisms behind Resistance to Chemo-Radiotherapeutic Agents Used in Cancer Treatment.
Krishnaraj J, Yamamoto T, Ohki R
Cancers (Basel). 2023; 15(13).
PMID: 37444509
PMC: 10341282.
DOI: 10.3390/cancers15133399.
PRMT5 supports multiple oncogenic pathways in mantle cell lymphoma.
Sloan S, Brown F, Long M, Weigel C, Koirala S, Chung J
Blood. 2023; 142(10):887-902.
PMID: 37267517
PMC: 10517215.
DOI: 10.1182/blood.2022019419.